BIOMAT Database Logo BIOMAT Database Logo

[Clinical analysis of 1,000 patients with prostate cancer]. 2006

Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Department of Urology, Niigata Cancer Center Hospital, Niigata, Japan.

OBJECTIVE Treatment outcomes for prostate cancer in our hospital were reported. METHODS We analyzed 1,009 patients with prostate cancer treated at Niigata Cancer Hospital between 1983 and 2003. RESULTS As for the clinical stage, 20 cases belonged to Stage I, 367 cases to Stage II, 269 cases to Stage III and 353 cases to Stage IV. The overall 5-year survival rate of the all 1,009 cases was 59.0%, comprising 78.2% for stage I, 82.0% for Stage II, 76.0% for Stage III and 30.0% for Stage IV cases. Disease-specific 5-year survival rates for Stage I, II, III and IV were 100%, 96.8%, 89.3% and 41.1% respectively. In Stage III patients, the radiotherapy (with endocrine therapy) group showed longer cause-specific survival than the endocrine therapy group (p = 0.0056). CONCLUSIONS Our result suggest that the radiotherapy with endocrine therapy is useful for Stage III prostate cancer.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
[Clinical analysis of 169 patients with prostate cancer].
August 1996, Hinyokika kiyo. Acta urologica Japonica,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
March 2007, The Journal of urology,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis.
January 2017, OncoTargets and therapy,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
[Peptic ulcers: clinical analysis of 1,000 cases].
January 1959, Zhonghua nei ke za zhi,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Treatment of patients with clinical T3 prostate cancer.
February 2002, Scandinavian journal of urology and nephrology,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Clinical use of prostate specific antigen in patients with prostate cancer.
October 1989, The Journal of urology,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
[Clinical analysis of 1,000 cases of premature deliveries].
January 1970, Ginekologia polska,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
[Clinical analysis of 1,000 cases of hysterical paralysis].
February 1983, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
[A clinical analysis of patients with early-stage prostate cancer managed without initial treatment].
March 2002, Hinyokika kiyo. Acta urologica Japonica,
Toshihiro Saito, and Takashi Kasahara, and Yasuo Kitamura, and Shuichi Komatsubara
Clinical outcome of patients with stage T1a prostate cancer.
April 2003, Journal of the Chinese Medical Association : JCMA,
Copied contents to your clipboard!